Shionogi
Shionogi supply the best possible medicine to protect the health and wellbeing of the patients they serve.
Launch date
Employees
Market cap
€12.5b
Enterprise valuation
€8.8b (Public information from Sep 2024)
Share price
JPY6428
Osaka Osaka Prefecture (HQ)
Financials
Estimates*
| EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 2.1b | 2.3b | 3.0b | 3.0b | 3.1b | 3.2b | 3.3b |
| % growth | (11 %) | 13 % | 27 % | 2 % | 1 % | 4 % | 3 % |
| EBITDA | 926m | 887m | 1.2b | 1.2b | 1.3b | 1.2b | 1.3b |
| % EBITDA margin | 44 % | 38 % | 39 % | 39 % | 41 % | 39 % | 39 % |
| Profit | 783m | 799m | 1.3b | 1.1b | 1.1b | 1.1b | 1.2b |
| % profit margin | 38 % | 34 % | 43 % | 37 % | 37 % | 35 % | 36 % |
| EV / revenue | 5.1x | 6.0x | 3.4x | 4.2x | 3.2x | 3.0x | 2.6x |
| EV / EBITDA | 11.5x | 16.0x | 8.8x | 10.7x | 7.8x | 7.6x | 6.7x |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Shionogi
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
ACQUISITION by Virtual Therapeutics May 2024
ACQUISITION by Shionogi Jul 2011
